Search - tctmd.com

Displaying 21 - 40 of 806

Sort: Relevancy | Date

Presentation TCT 2025

BIOADAPTOR-RCT 3 Year Outcomes and Bioadaptor Mechanism of Action

Presenter: Johan R. Bennett

October 26, 2025

Presentation TCT 2025

INFINITY-SWEDEHEART-RCT 1 Year Clinical Outcomes

Presenter: David Erlinge

October 26, 2025

Presentation TCT 2025

Current Status of Long-Term PCI Outcomes: Why it is Time to Rethink PCI Success

Presenter: David J. Cohen

October 26, 2025

Presentation TCT 2025

Welcone & Introductions

Presenter: Shigeru Saito

October 26, 2025

Presentation TCT 2025

TCT 189: Follow-up of Flow-Reserve-Guided Treatment for In-Stent Restenosis of Drug-Eluting Coronary Stents

Presenter: Kornel Kakonyi

October 26, 2025

Presentation TCT 2025

TCT 179: In-Stent Restenosis in Chronic Kidney Failure: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents

Presenter: Rafal Adam Januszek

October 26, 2025

Presentation TCT 2025

TCT 371: Drug-Coated Balloons Versus Drug-Eluting Stents for Side Branch Lesions in Coronary Bifurcations: A Systematic Review and Meta-Analysis

Presenter: Fernando Manuel Quevedo

October 26, 2025

Presentation TCT 2025

TCT 375: Optimizing Treatment for MEDINA 0.0.1 Bifurcation Lesions: A Comparative Evaluation of Drug-Coated Balloons and Drug-Eluting Stents

Presenter: Sunwon Kim

October 26, 2025

Presentation TCT 2025

TCT 174: A Comparative Analysis of Clinical Outcomes in Patients with In-Stent Restenosis Undergoing Percutaneous Coronary Intervention with Drug Coated Balloons and Drug Eluting Stents

Presenter: Haseeb Ur Rahman

October 26, 2025

Presentation TCT 2025

Abluminus Sirolimus DES+ vs. Everolimus-Eluting Stents in Patients with Diabetes Mellitus: Final 2-Year Results of the ABILITY Global Study

Presenter: Alexandre Abizaid

October 25, 2025

Presentation TCT 2025

Five-Year Outcomes of Biodegradable-Polymer Versus Durable-Polymer Second-Generation Drug-Eluting Stents: A Collaborative Individual Patient Data Analysis of 40,214 Patients Enrolled in 22 Randomized Trials

Presenter: Daniele Giacoppo

October 25, 2025

Presentation TCT 2025

TCT 1400: Fixing the Dislodged Peripheral Stent With Two Covered Stents During TAVI: The Dread of a Tavilogist

Presenter: Erhan Tenekecioglu

October 25, 2025

Presentation NY Valves 2025

Safety and Efficacy of Covered Stents for Managing Vascular Access Complications After Transfemoral Transcatheter Aortic Valve Replacements: A Systematic Review and Meta-analysis

Presenter: Osama Elkhateeb

June 27, 2025

Presentation Controversies and Advances 2025

Antianginals or Stents are Reasonable Alternatives for Patients with Symptomatic CAD

Presenter: Rasha Al-Lamee

January 31, 2025

Presentation TCT 2024

TCT 506: Comparison of Healing Pattern Using Optical Coherence Tomography in Small vs Large Coronary Arteries After Sirolimus-eluting Stents Implantation

Presenter: Atul Abhyankar

October 30, 2024

Presentation TCT 2024

TCT 507: Evaluating Vascular Response to Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients With Diabetes Mellitus Using Optical Coherence Tomography: The OCID Study

Presenter: Atul Abhyankar

October 30, 2024

Presentation TCT 2024

When Should I Use 2 Stents, Which Technique for Which Anatomy?

Presenter: Manish Parikh

October 30, 2024

Presentation TCT 2024

TCT 1190: Hostile Aorta: Valve, Grafts, Stents and Plug for Intervention

Presenter: Diego Bianchi

October 30, 2024

Presentation TCT 2024

TCT 261: Comparison of Clinical Outcomes Between First- and Second-Generation Drug-Eluting Stents in Single Vessel Disease Patients up to 10-Year Follow-up Results

Presenter: Woo Jin Ahn

October 30, 2024

Presentation TCT 2024

Are Metallic Drug Eluting Stents As Good As it Gets?

Presenter: Mahesh Madhavan

October 30, 2024

Advertisement

BIOADAPTOR-RCT 3 Year Outcomes and Bioadaptor Mechanism of Action

INFINITY-SWEDEHEART-RCT 1 Year Clinical Outcomes

Current Status of Long-Term PCI Outcomes: Why it is Time to Rethink PCI Success

Welcone & Introductions

TCT 189: Follow-up of Flow-Reserve-Guided Treatment for In-Stent Restenosis of Drug-Eluting Coronary Stents

TCT 179: In-Stent Restenosis in Chronic Kidney Failure: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents

TCT 371: Drug-Coated Balloons Versus Drug-Eluting Stents for Side Branch Lesions in Coronary Bifurcations: A Systematic Review and Meta-Analysis

TCT 375: Optimizing Treatment for MEDINA 0.0.1 Bifurcation Lesions: A Comparative Evaluation of Drug-Coated Balloons and Drug-Eluting Stents

TCT 174: A Comparative Analysis of Clinical Outcomes in Patients with In-Stent Restenosis Undergoing Percutaneous Coronary Intervention with Drug Coated Balloons and Drug Eluting Stents

Abluminus Sirolimus DES+ vs. Everolimus-Eluting Stents in Patients with Diabetes Mellitus: Final 2-Year Results of the ABILITY Global Study

Five-Year Outcomes of Biodegradable-Polymer Versus Durable-Polymer Second-Generation Drug-Eluting Stents: A Collaborative Individual Patient Data Analysis of 40,214 Patients Enrolled in 22 Randomized Trials

TCT 1400: Fixing the Dislodged Peripheral Stent With Two Covered Stents During TAVI: The Dread of a Tavilogist

Safety and Efficacy of Covered Stents for Managing Vascular Access Complications After Transfemoral Transcatheter Aortic Valve Replacements: A Systematic Review and Meta-analysis

Antianginals or Stents are Reasonable Alternatives for Patients with Symptomatic CAD

TCT 506: Comparison of Healing Pattern Using Optical Coherence Tomography in Small vs Large Coronary Arteries After Sirolimus-eluting Stents Implantation

TCT 507: Evaluating Vascular Response to Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients With Diabetes Mellitus Using Optical Coherence Tomography: The OCID Study

When Should I Use 2 Stents, Which Technique for Which Anatomy?

TCT 1190: Hostile Aorta: Valve, Grafts, Stents and Plug for Intervention

TCT 261: Comparison of Clinical Outcomes Between First- and Second-Generation Drug-Eluting Stents in Single Vessel Disease Patients up to 10-Year Follow-up Results

Are Metallic Drug Eluting Stents As Good As it Gets?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content